These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication. Gupta M; Mahanty S; Bray M; Ahmed R; Rollin PE J Virol; 2001 May; 75(10):4649-54. PubMed ID: 11312335 [TBL] [Abstract][Full Text] [Related]
16. Ebola-Reston virus infection among quarantined nonhuman primates--Texas, 1996. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1996 Apr; 45(15):314-6. PubMed ID: 8602131 [No Abstract] [Full Text] [Related]
17. Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. Towner JS; Paragas J; Dover JE; Gupta M; Goldsmith CS; Huggins JW; Nichol ST Virology; 2005 Feb; 332(1):20-7. PubMed ID: 15661137 [TBL] [Abstract][Full Text] [Related]
18. Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit. Smither SJ; Nelson M; Eastaugh L; Nunez A; Salguero FJ; Lever MS J Infect Dis; 2015 Oct; 212 Suppl 2():S336-45. PubMed ID: 26209682 [TBL] [Abstract][Full Text] [Related]
19. Ebola virus circulation in Africa: a balance between clinical expression and epidemiological silence. Gonzalez JP; Herbreteau V; Morvan J; Leroy EM Bull Soc Pathol Exot; 2005 Sep; 98(3):210-7. PubMed ID: 16267963 [TBL] [Abstract][Full Text] [Related]